Thomas D Mccoy, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 841 Hospital Road, Suite 2600, Indiana, PA 15701 Phone: 724-349-1630 Fax: 724-349-5713 |
Dr. Tracy Jo Gemmell, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 841 Hospital Rd Ste 2500, Indiana, PA 15701 Phone: 724-427-2797 Fax: 724-427-2715 |
Sharad B Ghate, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1265 Wayne Ave, Suite 104, Indiana, PA 15701 Phone: 724-349-7530 Fax: 724-349-7531 |
William L Lear, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1265 Wayne Ave, Suite 200, Indiana, PA 15701 Phone: 724-463-7210 Fax: 724-463-7326 |
Sandor Mecs, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 841 Hospital Rd Ste 2500, Indiana, PA 15701 Phone: 724-427-2797 Fax: 724-427-2715 |
Dr. Michael R Stever, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1075 Indian Springs Road, Indiana, PA 15701 Phone: 724-349-9560 Fax: 724-349-7624 |
Quiniece M Hurdle, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1265 Wayne Ave Ste 200, Indiana, PA 15701 Phone: 724-463-0225 Fax: 724-463-7326 |
News Archive
Lavender aromatherapy reduced preoperative anxiety in a study of ambulatory surgery patients undergoing procedures in general otolaryngology. The effect observed in the Laryngoscope Investigative Otolaryngology study was modest, however.
Biothera today reported positive results from its proof of concept Phase 2 clinical trial in 90 patients with advanced non-small cell lung cancer (NSCLC) at the American Association for Cancer Research and the International Association for the Study of Lung Cancer joint conference on the Molecular Origins of Lung Cancer in San Diego.
Cancer survival rates could improve soon with whole-genome sequencing, according to two studies published in the April 20, 2011, issue of the Journal of the American Medical Association that describe the first clinical applications of the high-tech process in patients with cancer.
PROLOR Biotech, Inc., today announced the pricing of its previously announced underwritten public offering of 6.5 million shares of its common stock at a price to the public of $5.00 per share.
› Verified 8 days ago